These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37397436)

  • 1. First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada.
    Bouck Z; Tricco AC; Rosella LC; Banack HR; Fox MP; Platt RW; Milloy MJ; DeBeck K; Hayashi K; Werb D
    Drug Alcohol Depend Rep; 2023 Jun; 7():100168. PubMed ID: 37397436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
    Geddes L; Iversen J; Wand H; Maher L
    Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid agonist treatment and the process of injection drug use initiation.
    Mittal ML; Jain S; Sun S; DeBeck K; Milloy MJ; Hayashi K; Hadland SE; Werb D
    Drug Alcohol Depend; 2019 Apr; 197():354-360. PubMed ID: 30922483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance.
    Meyers-Pantele SA; Mittal ML; Jain S; Sun S; Rammohan I; Fairbairn N; Milloy MJ; DeBeck K; Hayashi K; Werb D
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):39. PubMed ID: 35590419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico.
    Bowles JM; Jain S; Sun X; Strathdee SA; DeBeck K; Milloy MJ; Bouck Z; Werb D
    Int J Drug Policy; 2021 Sep; 95():103398. PubMed ID: 34390966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
    JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of recent homelessness on the provision of injection drug use initiation assistance among persons who inject drugs in Tijuana, Mexico and Vancouver, Canada.
    Marks C; Bouck Z; Jain S; Sun X; Strathdee SA; Vickerman P; DeBeck K; Milloy MJ; Hayashi K; Werb D
    Drug Alcohol Depend; 2021 Aug; 225():108829. PubMed ID: 34237582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis.
    Marks C; Borquez A; Jain S; Sun X; Strathdee SA; Garfein RS; Milloy MJ; DeBeck K; Cepeda JA; Werb D; Martin NK
    PLoS Med; 2019 Nov; 16(11):e1002973. PubMed ID: 31770373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA.
    Mittal ML; Vashishtha D; Sun S; Jain S; Cuevas-Mota J; Garfein R; Strathdee SA; Werb D
    Subst Abuse Treat Prev Policy; 2017 Oct; 12(1):42. PubMed ID: 28974239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and the first-time provision of injection initiation assistance among people who inject drugs across two distinct North American contexts: Tijuana, Mexico and Vancouver, Canada.
    Meyers-Pantele SA; Jain S; Sun X; Marks C; DeBeck K; Hayashi K; Strathdee SA; Werb D
    Drug Alcohol Rev; 2022 Mar; 41(3):686-696. PubMed ID: 34636100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.
    Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Farrell M; Hickman M; Webster D; Hayward A; Degenhardt L
    PLoS Med; 2022 Jul; 19(7):e1004049. PubMed ID: 35853024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Navigating social norms of injection initiation assistance during an overdose crisis: A qualitative study of the perspectives of people who inject drugs (PWID) in Vancouver, Canada.
    Olding M; Werb D; Guise A; Small W; McNeil R
    Int J Drug Policy; 2019 Jul; 69():24-33. PubMed ID: 31029914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.
    Bouck Z; Scheim AI; Gomes T; Ling V; Caudarella A; Werb D
    Int J Drug Policy; 2022 Jun; 104():103680. PubMed ID: 35447476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings.
    Marks C; Meyers SA; Jain S; Sun X; Hayashi K; Gonzalez-Zuniga P; Strathdee SA; Garfein RS; Milloy MJ; DeBeck K; Cummins K; Werb D
    BMJ Open; 2021 Aug; 11(8):e046957. PubMed ID: 34385244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis.
    Hajarizadeh B; Cunningham EB; Valerio H; Martinello M; Law M; Janjua NZ; Midgard H; Dalgard O; Dillon J; Hickman M; Bruneau J; Dore GJ; Grebely J
    J Hepatol; 2020 Apr; 72(4):643-657. PubMed ID: 31785345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
    Colledge-Frisby S; Rathnayake K; Nielsen S; Stoove M; Maher L; Agius PA; Higgs P; Dietze P
    JAMA Netw Open; 2023 Aug; 6(8):e2327319. PubMed ID: 37540514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study.
    Roux P; Faye A; Sagaon-Teyssier L; Donadille C; Briand Madrid L; Carrieri MP; Maradan G; Jauffret-Roustide M; Lalanne L; Auriacombe M;
    Drug Alcohol Rev; 2024 Oct; ():. PubMed ID: 39353607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
    Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.